invobioscience.com - IVF Total Company Value-to-Revenue Ratio

INVO Bioscience (IVF) - corporate logo

INVO Fertility Inc (IVF) focuses on expanding the ART market through affordable intravaginal culture technology. The company's price-to-sales ratio visualizes the dynamics of this process, where the 242.50 metric indicates the asset's status. Distribution efficiency is ensured through external incubator production and outsourced support. The firm is currently scaling the INVOcell system as a budget alternative to traditional IVF.

INVO Bioscience, Inc. (IVF) EV/Sales Multiple: for the period 11/23/2025 - 11/20/2026

Financial and market metric breakdowns for INVO Bioscience, Inc. (IVF)

- share price and consensus valuation forecast:
Fundamental company valuation:IVF, invobioscience.com
Flagship merchandise of INVO Bioscience

The stable staff of engineers and embryologists at INVO Fertility Inc (IVF) creates a foundation for revenue growth, making the analysis of enterprise value (EV) a key tool for assessing real assets. By examining the EV/Sales chart, an investor determines the market premium per unit of sales, identifying critical trend reversal points and evaluating the efficiency of the company's intellectual capital capitalization.

Competitor analysis

BSX (Boston Scientific) - Company Value to Revenue Ratio|EW: EV/Sales Multiple|RMD - Total Company Value-to-Revenue Ratio|PODD (Insulet Inc.) - EV/Sales Multiple|Company Value to Revenue Zimmer Biomet Corp (ZBH)|EV/Sales Multiple COO|Company Value to Revenue Align Technology, Inc. ALGN|EV/Sales Multiple GMED (globusmedical.com)|EV/Sales Multiple TransMedics Group, Inc. TMDX|ATEC - Enterprise Value-to-Revenue Ratio|AORT: Enterprise Value-to-Revenue Ratio|ENOV (Enovis Corporation) - Company Value to Revenue|Integra LifeSciences - Business Value to Revenue|ESTA (Establishment Labs Inc) - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple Beta Bionics, Inc. BBNX|Enterprise Value-to-Revenue Ratio IRADIMED Corp (IRMD)|Embecta Corp. (EMBC) - Enterprise Value-to-Sales Ratio|Tandem Corp - Company Value to Revenue|EV/Sales Multiple AxoGen, Inc. AXGN|SI-BONE Inc - EV/Sales Multiple|Total Company Value-to-Revenue Ratio Orthofix Medical OFIX|Bioventus Global (BVS) - Enterprise Value-to-Revenue Ratio|Enterprise Value to Sales Volume KIDS (OrthoPediatrics Inc.)|Enterprise Value-to-Revenue Ratio treace.com|Company Value to Revenue Strata Critical Medical Inc (SRTA)|EV/Sales Multiple CARL|RXST - Enterprise Value-to-Revenue Multiple|Enterprise Value-to-Revenue Ratio clearpointneuro.com CLPT|STXS: Company Value to Revenue Ratio|STIM: Company Value to Revenue|sightsciences.com - Enterprise Value-to-Revenue Coefficient|Orchestra BioMed Inc. (OBIO) - Enterprise Value-to-Revenue Ratio|Anika (ANIK) - EV/Sales Multiple|Enterprise Value-to-Revenue Ratio InspireMD, Inc.|zhjmedical.com (ZJYL) - Total Company Value-to-Revenue Ratio|Company Value to Revenue VANI (Vivani Medical)|EV/Sales Multiple Xtant Medical Holdings, Inc. (XTNT)|Enterprise Value-to-Revenue Ratio NeuroOne Medical Technologies Corporation NMTC|EV/Sales Multiple Modular Medical MODD|MYO: Company Value to Revenue|Enterprise Value-to-Revenue Multiple Envoy Medical, Inc.|VVOS (Vivos Therapeutics) - Company Value to Revenue|Company Value to Revenue Ratio NVNO|Company Value to Revenue SINT|Company Value to Revenue Tenon Medical (TNON)|Enterprise Value-to-Revenue Ratio ReWalk Robotics Ltd (LFWD)|Total Company Value-to-Revenue Ratio Autonomix|Enterprise Value-to-Revenue Ratio Bone Biologics BBLG|Total Company Value-to-Revenue Ratio axonics.com (AXNX)|BIOL - Enterprise Value-to-Revenue Ratio|Dynatronics (DYNT) - Company Value to Revenue|Paragon 28, Inc. (FNA) - Enterprise Value-to-Revenue Ratio|INVO - Total Company Value-to-Revenue Ratio